Steven Vlad is a Rheumatology/Immunology physician affiliated with Tufts University. OpenAlex indexes 24 publications with 1,880 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 Washington St
South 3
Boston, MA 021111552
Telephone
617-636-5990Provider last certified this registry record 1 Sept 2021.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year20222 payments
- ABBVIE INC.Program year20221 payment
- GlaxoSmithKline, LLC.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
29.9%TNF inhibitor8.7%Humira(Cf) Pen45%Enbrel Mini13%Enbrel12%Humira Pen12%Enbrel Sureclick11%Simponi6%Part D<11 patientsFolate Analog Metabolic Inhibitor6.8%Methotrexate84%Rasuvo16%Part D<11 patients+ 9 more classes in this area
Nervous system
25.8%Opioid Agonist11.5%Tramadol Hcl48%Oxycodone Hcl43%Oxycodone-Acetaminophen9%Part D<11 patientsGabapentinoids8.1%Gabapentin56%Pregabalin44%Part D≥24 patients+ 5 more classes in this area
Metabolism & gastrointestinal
22.4%Corticosteroid21.1%Prednisone100%Part D≥115 patientsProvitamin D2 Compound0.7%Vitamin D2100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2009–2013 per NIH RePORTER. The latest:
- Glucocorticoid Regimens and Cardiovascular Risk
Boston University Medical Campus
FY2012$129,345K23AR056301 - Glucocorticoid Regimens and Cardiovascular Risk
Boston University Medical Campus
FY2011$129,229K23AR056301
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Lesley Inker, MD
Tufts University
Nadia Waheed, MD
Tufts University
Helen Boucher, MD
Tufts University
Caroline Baumal, MD
Tufts University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”